Clinical Trial Update: ATGAM General Investigation

View source ↗

Summary

Pfizer's ATGAM anti-thymocyte globulin trial for aplastic anemia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• ATGAM (anti-thymocyte globulin (equine))

Snippet

Sponsor: Pfizer | Conditions: Aplastic Anemia | Status: ACTIVE_NOT_RECRUITING